About Proxim Diagnostics
Proxim Diagnostics is a company based in Sunnyvale (United States) founded in 2010.. Proxim Diagnostics has raised $22.9 million across 5 funding rounds from investors including BioMerieux. Proxim Diagnostics offers products and services including Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test. Proxim Diagnostics operates in a competitive market with competitors including GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others.
- Headquarter Sunnyvale, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Proxim Diagnostics Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$22.9 M (USD)
in 5 rounds
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Proxim Diagnostics
Proxim Diagnostics offers a comprehensive portfolio of products and services, including Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Portable device for accurate immunodiagnostic testing using whole blood.
Low-cost cartridges designed for various diagnostic tests.
Quantitative blood test for detecting pregnancy levels.
Blood test to identify sepsis markers in patients.
Unlock access to complete
Unlock access to complete
Funding Insights of Proxim Diagnostics
Proxim Diagnostics has successfully raised a total of $22.9M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(10 Nov 2010)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2023 | Amount | Series B - Proxim Diagnostics | Valuation | BioMerieux |
|
| Nov, 2022 | Amount | Series B - Proxim Diagnostics | Valuation |
investors |
|
| Sep, 2018 | Amount | Series A - Proxim Diagnostics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Proxim Diagnostics
Proxim Diagnostics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include BioMerieux. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Developer of diagnostics devices for multiple health purposes
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Proxim Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Proxim Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Proxim Diagnostics Comparisons
Competitors of Proxim Diagnostics
Proxim Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GEN inCode, SD Biosensor, SpectraWAVE, Lepu Medical Technology and Spectrum Dynamics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genetic and clinical data are integrated for precision cardiac medicines.
|
|
| domain | founded_year | HQ Location |
Biosensors for point-of-care diagnostics are developed by SD Biosensor.
|
|
| domain | founded_year | HQ Location |
Photonic imaging diagnostics for cardiovascular disease treatment are provided.
|
|
| domain | founded_year | HQ Location |
Interventional cardiology devices are developed and marketed globally.
|
|
| domain | founded_year | HQ Location |
Cardiac imaging systems are manufactured using advanced molecular technologies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Proxim Diagnostics
Frequently Asked Questions about Proxim Diagnostics
When was Proxim Diagnostics founded?
Proxim Diagnostics was founded in 2010.
Where is Proxim Diagnostics located?
Proxim Diagnostics is headquartered in Sunnyvale, United States. It is registered at Sunnyvale, California, United States.
Is Proxim Diagnostics a funded company?
Proxim Diagnostics is a funded company, having raised a total of $22.9M across 5 funding rounds to date. The company's 1st funding round was a Series A of $1.71M, raised on Nov 10, 2010.
What does Proxim Diagnostics do?
Proxim Diagnostics was founded in 2010 and is based in Sunnyvale, United States. Operations focus on the medical diagnostics sector, where a handheld immunodiagnostic device is developed for detecting cardiac vascular diseases. Capabilities include testing for cardiac markers, blood gases, electrolytes, metabolites, as well as infectious disease antigens and antibodies. The device supports point-of-care applications in healthcare settings.
Who are the top competitors of Proxim Diagnostics?
Proxim Diagnostics's top competitors include GEN inCode, SD Biosensor and SpectraWAVE.
What products or services does Proxim Diagnostics offer?
Proxim Diagnostics offers Handheld Immunodiagnostic Device, Test Cartridge, beta-hCG Test, and PCT Test.
Who are Proxim Diagnostics's investors?
Proxim Diagnostics has 1 investor. Key investors include BioMerieux.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.